Recent trends in the epidemiology of shigellosis in Israel

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2583-2594

  Cohen, D ^a   Bassal, R ^b   Goren, S ^a   Rouach, T ^c   Taran, D ^d   Schemberg, B ^d   Peled, N ^e   Keness, Y ^f   Ken Dror, S ^g   Vasilev, V ^h   Nissan, I ^h   Agmon, V ^h   Shohat, T ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c Leumit Research Institue   (Israel)

^d MACCABI HEALTHCARE SERVICES   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^f HAEMEK MEDICAL CENTER   (Israel)

^g CLALIT HEALTH SERVICES   (Israel)

^h Ministry of Health Central Laboratories   (Israel)

Author keywords

Antibiotic resistance; epidemics; host (in infections); Shigella; surveillance system

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; COTRIMAZINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; SEROTYPE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; TREND STUDY; YOUNG ADULT; DYSENTERY, BACILLARY; EPIDEMIOLOGY; INCIDENCE; INFANT; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; SENTINEL SURVEILLANCE;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ISRAEL; MALE; RISK FACTORS; SENTINEL SURVEILLANCE;

EID: 84911976407     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000260     Document Type: Article

References (44)

1. Kotloff KL, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 1999; 77: 651-666.
2. Voetsch AC, et al. Laboratory practices for stoolspecimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995- 2000. Clinical Infectious Diseases 2004; 38 (Suppl. 3): S190-197.
3. Bardhan P, et al. Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerging Infectious Diseases 2010; 16: 1718-1723.
4. Niyogi SK. Shigellosis. Journal of Microbiology 2005; 43: 133-143.
5. Ahmed F, et al. Epidemiology of post-shigellosis persistent diarrhea in young children. Pediatric Infectious Disease Journal 2001; 20: 525-530.
6. Bennish ML, Wojtyniak BJ. Mortality due to shigellosis - community and hospital data. Reviews of Infectious Diseases 1991; 13: S245-S251.
7. Black RE, et al. Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. American Journal of Epidemiology 1982; 115: 315-324.
8. Hyams KC, et al. Diarrheal disease during Operation Desert Shield. New England Journal of Medicine 1991; 325: 1423-1428.
9. DuPont HL, et al. Inoculum size in shigellosis and implications for expected mode of transmission. Journal of Infectious Diseases 1989; 159: 1126-1128.
10. Cohen D, et al. Reduction of transmission of shigellosis by control of houseflies (Musca domestica). Lancet 1991; 337: 993-997.
11. Green MS, et al. Four decades of shigellosis in Israel: epidemiology of a growing public health problem. Reviews of Infectious Diseases 1991; 13: 248-253.
12. Ostroi P, Anis E, Green MS. Shigellosis in Israel - update 1995. Public Health Reviews 1996; 24: 213-225.
13. Israel Center for Diseases Control and Division of Epidemiology Public Health Services MoH. Notifiable infectious diseases in Israel. 60 years of surveillance 1951-2010. Tel Hashomer: Ministry of Health, 2012.
14. Bauer AW, et al. Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 1966; 45: 493-496.
15. Standards NCfCL. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S9, 1999.
16. Ziv T, et al. Assessment of the underestimation of childhood diarrhoeal disease burden in Israel. Epidemiology and Infection 2011; 139: 1379-1387.
17. Chompook P, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bulletin of the World Health Organization 2005; 83: 739-746.
18. von Seidlein L, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine 2006; 3: e353.
19. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations 2011; 8:1
20. Egoz N, et al. An outbreak of Shigella sonnei infection due to contamination of a municipal water-supply in northern Israel. Journal of Infection 1991; 22: 87-93.
21. Gupta A, et al. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clinical Infectious Diseases 2004; 38: 1372-1377.
22. Lerman Y, et al. Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care-centers in a communal settlement (kibbutz). Journal of Clinical Microbiology 1994; 32: 1092-1094.
23. Sack DA, et al. Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides? Lancet 1994; 343: 1413-1415.
24. Vinh H, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infectious Diseases 2009; 9: 204.
25. Levine MM, et al. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nature Reviews Microbiology 2007; 5: 540-553.
26. Khan MU. Interruption of shigellosis by hand washing. Transactions of the Royal Society of Tropical Medicine and Hygiene 1982; 76: 164-168.
27. Pickering LK. The day care center diarrhea dilemma. American Journal of Public Health 1986; 76: 623-624.
28. Pickering LK, et al. Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. Journal of Pediatrics 1981; 99: 51-56.
29. Shane AL, et al. Sharing Shigella: risk factors for a multicommunity outbreak of shigellosis. Archives of Pediatrics & Adolescent Medicine 2003; 157: 601-603.
30. Mohle-Boetani JC, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. American Journal of Public Health 1995; 85: 812-816.
31. Garrett V, et al. A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission. Epidemiology and Infection 2006; 134: 1231-1236.
32. Green MS, et al. The changing epidemiology of viral hepatitis A in Israel. Israel Medical Association Journal 2001; 3: 347-351.
33. Rosenberg ML, et al. Shigella surveillance in the United States, 1975. Journal of Infectious Diseases 1977; 136: 458-460.
34. Herrington DA, et al. Studies in volunteers to evaluate candidate Shigella vaccines - further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 1990; 8: 353-357.
35. Ferreccio C, et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. American Journal of Epidemiology 1991; 134: 614-627.
36. Cohen D, et al. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. Journal of Infectious Diseases 1988; 157: 1068-1071.
37. Cohen D, et al. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. Journal of Clinical Microbiology 1991; 29: 386-389.
38. Mates A, Eyny D, Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990- 1995. European Journal of Clinical Microbiology 2000; 19: 108-111.
39. Vasilev V, et al. Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000-2002. Epidemiology and Infection 2004; 132: 1049-1054.
40. Vrints M, et al. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. Journal of Clinical Microbiology 2009; 47: 1379-1385.
41. Shiferaw B, et al. Antimicrobial Susceptibility Patterns of Shigella Isolates in Foodborne Diseases Active Surveillance Network (FoodNet) Sites, 2000-2010. Clinical Infectious Diseases 2012; 54: S458-S463.
42. Wong MR, et al. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009. Microbial Drug Resistance 2010; 16: 155-161.
43. Kosek M, et al. Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics 2008; 122: e541-549.
44. Banga Singh KK, et al. A 9-year study of shigellosis in Northeast Malaysia: Antimicrobial susceptibility and shifting species dominance. Zeitschrift fur Gesundheitswissenschaften 2011; 19: 231-236.